PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.06%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
4.38%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
10.11%
EBIT growth above 1.5x ADI's 3.04%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
9.21%
Operating income growth above 1.5x ADI's 3.04%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
7.23%
Net income growth above 1.5x ADI's 3.64%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
6.98%
EPS growth above 1.5x ADI's 3.13%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
7.94%
Diluted EPS growth above 1.5x ADI's 3.16%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.21%
Share reduction while ADI is at 0.15%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.31%
Reduced diluted shares while ADI is at 0.22%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.06%
Dividend reduction while ADI stands at 12.09%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
62.24%
OCF growth at 75-90% of ADI's 80.46%. Bill Ackman would demand better working capital management or cost discipline.
76.64%
FCF growth 50-75% of ADI's 112.15%. Martin Whitman would see if structural disadvantages exist in generating free cash.
101.87%
10Y revenue/share CAGR at 50-75% of ADI's 153.62%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
27.36%
5Y revenue/share CAGR under 50% of ADI's 86.61%. Michael Burry would suspect a significant competitive gap or product weakness.
20.00%
3Y revenue/share CAGR under 50% of ADI's 63.93%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
336.00%
10Y OCF/share CAGR at 50-75% of ADI's 596.26%. Martin Whitman might fear a structural deficiency in operational efficiency.
164.88%
5Y OCF/share CAGR 1.25-1.5x ADI's 138.89%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
79.90%
3Y OCF/share CAGR similar to ADI's 75.21%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
578.69%
Net income/share CAGR 1.25-1.5x ADI's 460.72%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
118.39%
5Y net income/share CAGR above 1.5x ADI's 66.66%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
70.62%
3Y net income/share CAGR 75-90% of ADI's 80.39%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
24.55%
Below 50% of ADI's 282.65%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.32%
Negative 5Y equity/share growth while ADI is at 102.15%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-8.78%
Negative 3Y equity/share growth while ADI is at 101.48%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
602.36%
10Y dividend/share CAGR above 1.5x ADI's 170.52%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
155.50%
5Y dividend/share CAGR above 1.5x ADI's 46.27%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
102.39%
3Y dividend/share CAGR above 1.5x ADI's 28.41%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-1.46%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.44%
Inventory is declining while ADI stands at 2.51%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.34%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.17%
We have a declining book value while ADI shows 1.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.10%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.26%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
1.45%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.